Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Business > Six Sigma Requires a Substantial Commitment from “Informal” Leaders

Tags

  • drugs
  • mavens
  • product
  • combination products
  • informal leaders

  • Links

  • Shakespeare Biography
  • The Reluctant Entrepreneur
  • Which Remote Key Logger Should You Choose?
  • Digg It - Six Sigma Requires a Substantial Commitment from “Informal” Leaders

    An awful lot has been said lately about Six Sigma and its abilities to bring out the full potential in any business or organization. Ho
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    wever, the aspect – other than money – that most frequently causes a company to stop in its tracks when confronted with the option of ta
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    king on a Six Sigma strategy is the fact that it requires such a substantial leadership commitment.

    This being said, leadership doesn’t
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    just mean the people at the top of the company hierarchy. Leadership commitment in this sense is required by all leaders in the busines
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    s, whether they be presidents, CEO’s, team leaders, or “informal” leaders.

    In fact, it is these informal leaders who are being recogniz
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ed as among the most highly influential in the success of Six Sigma implementation in a business. Such informal leaders are recognized
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    s coming from three primary groups. These can be connectors, mavens, and salespeople.

    • Connectors – these are individuals in a busine
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ss who are able to naturally build rapport with other employees, customers, and clients. These are the first people that should be ident
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ified for implementing Six Sigma in a business. They are at the heart of influence in the organization, knowing everyone, often performi
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    g introductions, and frequently performing a great deal of networking and referrals.

    • Mavens – these people are the individuals who ar
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    e responsible for connecting employees with the technology utilized within the business. Since they are at the core of technology chang
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    es and introductions in the company, they are a natural part of the Six Sigma execution, it is vital to have them identified and prepare
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    .

    • Salespeople – these are the people who are in it for the cash. They work for the reward that they receive. They need to see Six S
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    igma as a path to personal gain. If this is done successfully, they will help to spread Six Sigma throughout the rest of the business.
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen

    Each of these types of informal leaders will play a vital and irreplaceable role in the “social structure” of the Six Sigma implementat
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    on process. They are the motivation, application, and practicality element that is so critical to the successful introduction and maint
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    enance of Six Sigma. They are also the people who prevent alienation, confusion, and resistance to change in the processes of the busin
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ess.

    Keeping informal leaders out of the Six Sigma loop is a direct path to failure. They will resent being left out, and the most imp
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    rtant procedural influences will be lacking.

    Therefore, make sure that you have well trained – occasionally black-belt trained – Six Si
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    gma informal leaders throughout your business to get the ball rolling, and to be certain that it is always headed in the right direction


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/3379/diggit-Six-Sigma-Requires-a-Substantial-Commitment-from-Informal-Leaders.html">Six Sigma Requires a Substantial Commitment from “Informal” Leaders</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/3379/diggit-Six-Sigma-Requires-a-Substantial-Commitment-from-Informal-Leaders.html]Six Sigma Requires a Substantial Commitment from “Informal” Leaders[/url]

    Related Articles:

    The Ready Fundraising Company

    Quick Turning vs Speculation in Commercial Real Estate

    Things You Should Know About Arab Culture and Business Culture

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com